Candida auris in a tertiary healthcare setting in south India: A case series.

Asem Ali Ashraf, Rohan Steve Pinto, Vimal Kumar Karnaker
{"title":"<i>Candida auris</i> in a tertiary healthcare setting in south India: A case series.","authors":"Asem Ali Ashraf, Rohan Steve Pinto, Vimal Kumar Karnaker","doi":"10.22034/CMM.2024.345186.1502","DOIUrl":null,"url":null,"abstract":"<p><p><i>Candida</i> species can produce a variety of clinical manifestations, and several non-<i>albicans</i> species of <i>Candida</i>, including <i>Candida auris</i>, have been linked to the rise of invasive fungal infections with high rates of treatment failure. Nosocomial outbreaks and high mortality rates in healthcare institutions across the globe have been associated with <i>C. auris</i>, an emerging infectious yeast that was initially discovered in the ear canal of an elderly Japanese patient in 2009. The fact that <i>C. auris</i> has been found on six continents after it was initially isolated has raised serious concerns among scientists and healthcare practitioners. At present, healthcare facilities lack defined protocols for the effective prevention and control of <i>C. auris</i> infections, as well as appropriate treatment alternatives. This leads to frequent therapeutic failures and complicates the eradication of <i>C. auris</i> infection in healthcare facilities. Studies on <i>C. auris</i> in South India are often limited, and healthcare workers urgently need to be made aware of infections caused by it in order to assess its impact and possible implications for the healthcare system. This study aimed to report seven patients hospitalized in our center who developed <i>C. auris</i> infections with varying clinical manifestations.</p>","PeriodicalId":10863,"journal":{"name":"Current Medical Mycology","volume":"9 4","pages":"33-38"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11230147/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Medical Mycology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22034/CMM.2024.345186.1502","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Candida species can produce a variety of clinical manifestations, and several non-albicans species of Candida, including Candida auris, have been linked to the rise of invasive fungal infections with high rates of treatment failure. Nosocomial outbreaks and high mortality rates in healthcare institutions across the globe have been associated with C. auris, an emerging infectious yeast that was initially discovered in the ear canal of an elderly Japanese patient in 2009. The fact that C. auris has been found on six continents after it was initially isolated has raised serious concerns among scientists and healthcare practitioners. At present, healthcare facilities lack defined protocols for the effective prevention and control of C. auris infections, as well as appropriate treatment alternatives. This leads to frequent therapeutic failures and complicates the eradication of C. auris infection in healthcare facilities. Studies on C. auris in South India are often limited, and healthcare workers urgently need to be made aware of infections caused by it in order to assess its impact and possible implications for the healthcare system. This study aimed to report seven patients hospitalized in our center who developed C. auris infections with varying clinical manifestations.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
印度南部三级医疗机构中的念珠菌:病例系列。
念珠菌可产生多种临床表现,而包括阿氏念珠菌在内的几种非阿氏念珠菌与侵袭性真菌感染的增加和高治疗失败率有关。全球医疗机构中的非医院性疫情和高死亡率都与 C. auris 有关,这种新出现的传染性酵母菌最初于 2009 年在一名日本老年患者的耳道中被发现。在最初分离出 C. auris 后,又在六大洲发现了这种酵母菌,这引起了科学家和医疗从业人员的严重关切。目前,医疗机构缺乏有效预防和控制 C. auris 感染的明确方案以及适当的替代治疗方法。这导致治疗经常失败,使医疗机构根除法氏囊虫感染的工作变得更加复杂。南印度对 C. auris 的研究通常很有限,医护人员迫切需要了解由 C. auris 引起的感染,以评估其对医疗系统的影响和可能造成的后果。本研究旨在报告七名在本中心住院的患者,他们感染了阿氏杆菌,临床表现各不相同。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current Medical Mycology
Current Medical Mycology Medicine-Infectious Diseases
CiteScore
2.10
自引率
0.00%
发文量
16
审稿时长
4 weeks
期刊最新文献
Effect of yeast probiotic Saccharomyces boulardii cell wall extract on Aspergillus fumigatus allergenicity in A549 cells. Enhanced in-vitro anti-Candida efficacy of Euphorbia milii Des Moul mediated copper nanoparticles against clinically isolated Candida albicans. Evaluation of exoenzyme profiles of Candida albicans species isolated from females with vaginal candidiasis. Candida auris in a tertiary healthcare setting in south India: A case series. In vitro antifungal activity of biosynthesized selenium nanoparticles using plant extracts and six comparators against clinical Fusarium strains.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1